Quality of Life: The Concept

Aaronson NK , Beckman J. The Quality of Life of Cancer Patients. Monograph Series of the European Organization for Research on Treatment of Cancer (EORTC). Vol 17. New York: Raven Press, 1987.

Barofsky I , Sugarbaker P. Cancer. In Spilker B (ed), Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990, pp 419–439.

Cella DF , Cherin EA . Quality of life during and after cancer treatment. Comprehensive Ther 1988; 14 (5):69–75.

Cella DF , Tulsky DS . Measuring quality of life today: Methodological aspects. Oncol 4 1990; 5: 29–38.

Fayers PM , Jones DR . Measuring and analyzing quality of life in cancer clinical trials: A review. Statistics in Med 1983; 2:429–446.

Osoba D (ed). Effect of Cancer on Quality of Life. Boca Raton, Florida: CRC Press, 1991.

Schipper H , Levitt M. Measuring quality of life: Risks and benefits. Cancer Treat Rep 1985; 69:1115–1123.

American Cancer Society. Cancer Facts and Figures 1992. Atlanta, Georgia: American Cancer Society, 1992.

Johnson JR , Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985; 69:1155–1157.

Padilla GV , Ferrell B , Grant MM , Rhiner M. Defining the content domain of quality of life for cancer patients with pain. Cancer Nurs 1990; 13:108–115.

Padilla GV , Mishel MH , Grant MM . Uncertainty, appraisal and quality of life. Quality of Life Res 1992; 1:155–165.

Mishel MH . Reconceptualization of the uncertainty in illness theory. Image: J Nurs Scholarship 1990; 22:256–264.

Stewart AL , Ware JE , Brook RH . Advances in the measurement of functional status: Construction of aggregate indexes. Med Care 1981; 19:473–488.

Hays RD , Stewart AL . The structure of self-reported health in chronic disease patients. Psychological Assessment: A J Consult Clin Psychol 1990; 2 (1):22–30.

Aaronson NK , Bullinger M , Admedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results in Cancer Research 111. Berlin: Springer-Verlag, 1988, pp 231–249.

Ware JE , Sherbourne CD . A 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care, in press.

Stewart AL , Greenfield S , Hays RD , Wells K , Rogers WH , Berry SD , McGlynn EA , Ware JE . Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study. JAMA 1989; 262:907–913.

Karnofsky DA , Burchenal JH . The clinical evaluation of chemotherapeutic agents in cancer. In McCleod CM (ed). Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp 191–205.

Zubrod CG , Schneiderman M , Frei E , Brindley C , Gold GL , Shnider B , Orieto C , Gorman J , Jones R , Jonsson R , Colsky J , Chalmers T , Ferguson B , Dederick M , Holland J , Selawry O , Regelson W , Lasagna L , Owens AH . Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960; 11:7–33.

Bernheim JL , Buyse M. The Anamnestic Comparative Self Assessment for measuring the subjective quality of life of cancer patients. J Psychosoc Oncol 1984; 1 (4):25–38.

Gough IR , Furnival CM , Schilder L , Grove W. Assessment of the quality of life of patients with advanced cancer. Eur J. Cancer Clin Oncol 1983; 19:1161–1165.

Katz ST , Ford AB , Moskowite RW , Jackson BA , Jaffee MW . Studies of illness in the aged: The Index of ADL. JAMA 1963; 185:914–919.

Aaronson NK . Methodological issues in psychosocialoncology with special reference to clinical trials. In Ventafridda V , van Dam FSAM , Yancik R , Tamburini M (eds). Assessment of Quality of Life and Cancer Treatment. Amsterdam: Elsevier, 1986, pp 29–42.

Cella DF . Functional status and quality of life: Current views on measurement and intervention. In Functional Status and Quality of Life in Persons with Cancer. Atlanta, Georgia: American Cancer Society, 1991, pp 1–12.

Schipper H. Clinch J. McMurray A , Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: Development and validation. J Clin Oncol 1984; 2:472–483.

Cella DF . Manual: Functional Assessment of Cancer Therapy (FACT) Scales. Chicago: Unpublished manual.

De Haes JCJM , Raatgever JW , van der Bug MEL , Hamersma E , Neijt JP . Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy. In Aaronson NK , Beckman J (eds). The Quality of Life of Cancer Patients. New York: Raven Press, 1987, pp 215–226.

Cella DJ , Tross S , Orav EJ , Holland JC , Silberfarb PM , Rafla S. Mood states of patients after the diagnosis of cancer. J Psychosoc Oncol 1989; 7(1/2): 45–54.

Guadagnoli E , Mor V. Measuring cancer patients’ affect: Revision and psychometric properties of the Profile of Mood States (POMS). Psychological Assessment: A J Consult Clin Psychol 1989; 1 (2):150–154.

Ware JE , Snyder MK , Wright WR , Davies AR . Defining and measuring patient satisfaction with medical care. Evaluation and Program Planning 1983; 6:247–263.

Donovan K , Sanson-Fisher RW , Redman S. Measuring quality of life in cancer patients. J Clin Oncol 1989; 7:959–968.

Schag CC , Heinrich RL . CARES: CAncer Rehabilitation Evaluation System. Los Angeles, California: CARES Consultants, 1988.

Ganz PA , Schag CAC , Lee JJ , Sim M-S . The CARES: A generic measure of health-related quality of life for patients with cancer. Quality of Life Res 1992; 1:19–29.

Bergner M , Bobbitt RA , Pollard WE . Sickness Impact Profile: Validation of a health status measure. Med Care 1976; 14:57–61.

Bergner M , Bobbitt RA , Carter WB , Gilson BS . The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981; 19:787–806.

Baum M , Priestman T , West RR , Jones EM . A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer 1980; 16 (Suppl 1): 223–226.

Coates A , Gebsky V , Bishop JF . Improving the quality of life during chemotherapy for advanced breast cancer. New Engl J Med 1987; 317:1490–1495.

Silberfarb PM , Holland JCB , Anbar D , Bahna G , Maure LH , Chahinian AP , Comis R. Psychological response of patients receiving two drug regimens for lung carcinoma. Am J Psychiat 1983; 140:110–111.

Silberfarb PM , Maurer LH , Crouthamel . Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. Am J Psychiat 1980; 137:450–455.

Sugarbaker PH , Barofsky I , Rosenberg SA . Quality of life assessment of patients in extremity sarcoma trials. Surgery 1982; 91:17–23.

Ruckdeschel JC , Piantadosi S. Assessment of quality of life by the Functional Living Index—Cancer (FLIC) is superior to performance status for prediction of survival in patients with lung cancer. Proc Am Soc Clin Oncol 1989; 8: 311 (#1209).

Ganz PA , Lee JJ , Siau J. Quality of life assessment: An independent prognostic variable for survival in lung cancer. Cancer 1991; 67:3131–3135.